bezafibrate has been researched along with Rhabdomyolysis in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (16.00) | 18.7374 |
| 1990's | 10 (40.00) | 18.2507 |
| 2000's | 8 (32.00) | 29.6817 |
| 2010's | 2 (8.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoshida, T; Kimura, A; Maeda, A; Mastuda, T; Nishida, S; Takeda, T; Tanabe, K; Tsubaki, M; Yanae, M | 1 |
| Andresen, BS; Bastin, J; Benoist, JF; Boutron, A; de Lonlay, P; Djouadi, F; Ferdinandusse, S; Fukao, T; Habarou, F; Le Bachelier, C; Olpin, S; Schlemmer, D; Strauss, AW; Visser, G; Wanders, RJ; Yamaguchi, S | 1 |
| Bastin, J; Behin, A; Bonnefont, JP; Djouadi, F | 1 |
| Aubey, F; Bastin, J; Behin, A; Bonnefont, JP; Bresson, JL; Djouadi, F; Eymard, B; Gobin-Limballe, S; Laforêt, P; Mogenet, A; Ricquier, D; Romano, S; Vassault, A | 1 |
| Matsuyama, K; Matzno, S; Mishima, M; Nakabayashi, T; Tanaka, H; Tazuya-Murayama, K; Uchida, T; Yasuda, S | 1 |
| Fang, CC; Lee, YT; Su, TC; Yang, KC | 1 |
| Fujioka, Y; Masai, M; Morimoto, S; Ohyanagi, M; Okumura, T; Sakoda, T; Tsujino, T; Tsutsumi, C; Yuba, M | 1 |
| Bauer, K; Gabl, F; Haubenstock, A; Schmidt, P; Schröcksnadel, W | 1 |
| Balcke, P; Haubenstock, A; Kopsa, H; Schmidt, P; Sertl, K; Zazgornik, J | 1 |
| Arnold, R; Barth, M; Blech, M; Kaiser, H; Koop, I; Rumpf, KW; Scheler, F | 1 |
| Bedani, PL; Gilli, P; Perini, L | 1 |
| Fusegawa, H; Kawashima, N; Sato, F; Shindo, R | 1 |
| Alcoy, E; García-Ramos, JL; Górriz, JL; Pallardó, LM; Sancho, A | 1 |
| Cutrupi, S; Enia, G; Panuccio, V; Parlongo, S; Zoccali, C | 1 |
| Michigishi, T; Takayama, T; Taki, J; Tonami, N; Tsuji, S | 1 |
| Elisaf, MS; Milionis, HJ; Terrovitou, CT | 1 |
| Madden, BP; Millner, R; Parker, J; Rolfe, LM; Seymour, CA; Sharobeem, KM | 1 |
| Ben-Chetrit, S; Bernheim, J; Korzets, Z; Mor, A; Plotkin, E | 1 |
| Kamaliah, MD; Sanjay, LD | 1 |
| Muscari, A; Puddu, GM; Puddu, P | 1 |
| Inoue, M; Jimi, T; Machida, H; Niwa, Y; Wakayama, Y | 1 |
| Gas, JM; Perdiguero, M; Prados, MC; Rivera, F | 1 |
| Autonell, J; Brugués, J; Kanterewicz, E; Riba, J; Sanmartí, R; Trias, I | 1 |
| Cordi, GC; Corsi, L; Dapelo, M; De Micheli, A; Grimaldi, GP; Venzano, C | 1 |
| Benker, G; Cissewski, K; Kienast, K; Reinwein, D; Windeck, R | 1 |
2 review(s) available for bezafibrate and Rhabdomyolysis
| Article | Year |
|---|---|
Lipid-lowering drugs: are adverse effects predictable and reversible?
Topics: Aryl Hydrocarbon Hydroxylases; Bezafibrate; Cholesterol, LDL; Cytochrome P-450 Enzyme System; Digestive System; Drug Therapy, Combination; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Liver; Renal Insufficiency; Rhabdomyolysis; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases | 2002 |
Bezafibrate induced rhabdomyolysis.
Topics: Aged; Bezafibrate; Female; Humans; Hypercholesterolemia; Hypertension; Indomethacin; Rhabdomyolysis | 1992 |
1 trial(s) available for bezafibrate and Rhabdomyolysis
| Article | Year |
|---|---|
Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency.
Topics: Activities of Daily Living; Acyl-CoA Dehydrogenase, Long-Chain; Adult; Bezafibrate; Carnitine O-Palmitoyltransferase; Exercise Test; Female; Follow-Up Studies; Gene Expression Regulation, Enzymologic; Humans; Hypolipidemic Agents; Lymphocytes; Male; Middle Aged; Mitochondria, Muscle; Muscle, Skeletal; Muscular Diseases; Oxidation-Reduction; Oxygen Consumption; Pain; Palmitoyl Coenzyme A; Pilot Projects; Rhabdomyolysis; Treatment Outcome; Young Adult | 2010 |
22 other study(ies) available for bezafibrate and Rhabdomyolysis
| Article | Year |
|---|---|
Combination treatment with statins and bezafibrate induces myotoxicity via inhibition of geranylgeranyl pyrophosphate biosynthesis and Rho activation in L6 myoblasts and myotube cells.
Topics: Animals; Bezafibrate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscle Fibers, Skeletal; Myoblasts; Myotoxicity; Polyisoprenyl Phosphates; Rats; Rhabdomyolysis | 2022 |
Mitochondrial trifunctional protein deficiency in human cultured fibroblasts: effects of bezafibrate.
Topics: Bezafibrate; Cardiomyopathies; Cell Line; Fibroblasts; Genotype; Humans; Hypolipidemic Agents; Lipid Metabolism, Inborn Errors; Mitochondrial Myopathies; Mitochondrial Trifunctional Protein; Mitochondrial Trifunctional Protein, alpha Subunit; Mitochondrial Trifunctional Protein, beta Subunit; Mutation; Nervous System Diseases; Rhabdomyolysis | 2016 |
Bezafibrate for an inborn mitochondrial beta-oxidation defect.
Topics: Adult; Bezafibrate; Carnitine O-Palmitoyltransferase; Genes, Recessive; Humans; Hypolipidemic Agents; Lipid Metabolism, Inborn Errors; Mitochondrial Diseases; Oxidation-Reduction; Palmitoylcarnitine; Pilot Projects; Quality of Life; Rhabdomyolysis; RNA, Messenger; Statistics, Nonparametric | 2009 |
Evaluation of the synergistic adverse effects of concomitant therapy with statins and fibrates on rhabdomyolysis.
Topics: Animals; Apoptosis; Bezafibrate; Cells, Cultured; DNA Fragmentation; Drug Synergism; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipids; Myoblasts; Rats; Rhabdomyolysis; Structure-Activity Relationship | 2003 |
Treatment of fibrate-induced rhabdomyolysis with plasma exchange in ESRD.
Topics: Bezafibrate; Combined Modality Therapy; Female; Glomerulonephritis; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Kidney Failure, Chronic; Middle Aged; Plasma Exchange; Renal Dialysis; Rhabdomyolysis | 2005 |
Mizoribine-induced rhabdomyolysis in a rheumatoid arthritis patient receiving bezafibrate treatment.
Topics: Arthritis, Rheumatoid; Bezafibrate; Drug Interactions; Female; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Middle Aged; Rhabdomyolysis; Ribonucleosides | 2005 |
Predominance of lactate dehydrogenase isoenzyme 1 in a patient with bezafibrate-induced rhabdomyolysis.
Topics: Adult; Bezafibrate; Humans; Isoenzymes; L-Lactate Dehydrogenase; Male; Rhabdomyolysis | 1984 |
[Bezafibrate-induced rhabdomyolysis in a patient with impaired kidney function].
Topics: Adult; Bezafibrate; Humans; Kidney; Kidney Failure, Chronic; Male; Rhabdomyolysis | 1984 |
[Bezafibrate-induced myolysis and myoglobinuria in patients with impaired renal function].
Topics: Aged; Bezafibrate; Creatine Kinase; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myoglobin; Myoglobinuria; Rhabdomyolysis | 1984 |
Acute rhabdomyolysis and hemoglobin reduction after bezafibrate overdose in hyperlipidemic patients on hemodialysis.
Topics: Acute Disease; Bezafibrate; Drug Overdose; Hemoglobins; Humans; Hyperlipidemias; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Rhabdomyolysis | 1994 |
[Case of secondary carnitine deficiency (in a patient undergoing hemodialysis), developing rhabdomyolysis due to dehydration and the action of a hypolipemic agent].
Topics: Adult; Bezafibrate; Carnitine; Dehydration; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Rhabdomyolysis | 1993 |
Rhabdomyolysis and acute renal failure associated with bezafibrate treatment.
Topics: Acute Kidney Injury; Aged; Bezafibrate; Humans; Hypolipidemic Agents; Male; Rhabdomyolysis | 1995 |
Severe rhabdomyolysis induced by a retard formulation of bezafibrate in a CAPD patient.
Topics: Bezafibrate; Delayed-Action Preparations; Female; Humans; Hypolipidemic Agents; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Polycystic Kidney Diseases; Rhabdomyolysis | 1996 |
Bone scintigraphy of drug-induced rhabdomyolysis: antihyperlipidemia agent.
Topics: Bezafibrate; Bone and Bones; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Muscle, Skeletal; Radionuclide Imaging; Rhabdomyolysis | 1996 |
Acute rhabdomyolysis after bezafibrate re-exposure.
Topics: Aged; Bezafibrate; Female; Humans; Hypolipidemic Agents; Rhabdomyolysis | 1998 |
Acute renal failure after cardiopulmonary bypass: a possible association with drugs of the fibrate group.
Topics: Acute Kidney Injury; Aged; Anticholesteremic Agents; Bezafibrate; Cardiopulmonary Bypass; Clofibric Acid; Female; Fibric Acids; Humans; Male; Middle Aged; Rhabdomyolysis | 2000 |
Influenza vaccine--a possible trigger of rhabdomyolysis induced acute renal failure due to the combined use of cerivastatin and bezafibrate.
Topics: Acute Kidney Injury; Aged; Bezafibrate; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Influenza Vaccines; Male; Pyridines; Rhabdomyolysis | 2000 |
Rhabdomyolysis and acute renal failure following a switchover of therapy between two fibric acid derivatives.
Topics: Acute Kidney Injury; Aged; Bezafibrate; Coronary Disease; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney Diseases; Male; Rhabdomyolysis | 2001 |
[Bezafibrate myopathy in two patients with chronic renal failure].
Topics: Aged; Bezafibrate; Humans; Hyperlipidemias; Kidney Failure, Chronic; Male; Middle Aged; Molecular Weight; Rhabdomyolysis | 1992 |
[Rhabdomyolysis due to bezafibrate: a new case].
Topics: Bezafibrate; Female; Humans; Middle Aged; Rhabdomyolysis | 1992 |
[A case of acute rhabdomyolysis and acute renal insufficiency caused by the simultaneous use of furosemide and bezafibrate].
Topics: Acute Disease; Acute Kidney Injury; Aged; Bezafibrate; Female; Furosemide; Humans; Rhabdomyolysis | 1990 |
[Bezafibrate-induced myoglobinuric kidney failure in a 54-year-old patient with diabetes mellitus type IIa].
Topics: Acute Kidney Injury; Bezafibrate; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Middle Aged; Myoglobinuria; Rhabdomyolysis | 1988 |